Both in Pharmaceuticals
Nkarta vs Pyxis Oncology
Over the past year NKTX returned −22.1% and PYXS returned −50.1%; their daily moves had a correlation of 0.20.
NKTX −22.1% PYXS −50.1%Growth of $1, one year, split-adjusted
| Metric | NKTX | PYXS |
|---|---|---|
| Price | $1.83 | $1.69 |
| Market cap | $131.1M | $141.0M |
| Today | +2.23% | +0.60% |
| 1 month | −33.5% | −40.9% |
| 6 months | −35.3% | −4.0% |
| Year to date | −1.1% | +47.0% |
| 1 year | −19.0% | −50.0% |
| Revenue growth (YoY) | — | −100.0% |
| Gross margin | — | — |
| Net margin | — | — |
| P/E (TTM) | — | — |
| Price / sales | — | 12.8× |
| Net cash | $182.8M | $33.0M |
| Dividend yield | — | — |
| Volatility (60d) | 61.3% | 119.7% |
| Short % of float | 8.1% | 7.9% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).